Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 12
Submit an article Journal homepage
3,817
Views
87
CrossRef citations to date
0
Altmetric
Original Research

Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles

Vanesa G. MartinezSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
,
Sadhbh O'NeillSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
,
Josephine SalimuInstitute of Cancer and Genetics, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff, Wales
,
Susan BreslinSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
,
Aled ClaytonInstitute of Cancer and Genetics, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff, Wales
,
John CrownDepartment of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland
&
Lorraine O'DriscollSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, IrelandCorrespondence[email protected]
 show all
Article: e1362530 | Received 22 Jun 2017, Accepted 28 Jul 2017, Published online: 14 Sep 2017

Citations (87)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carolina Soekmadji, Bo Li, Yiyao Huang, Haifang Wang, Taixue An, Chunchen Liu, Weilun Pan, Jing Chen, Lesley Cheung, Juan Manuel Falcon-Perez, Yong Song Gho, Harry B. Holthofer, Minh T. N. Le, Antonio Marcilla, Lorraine O’Driscoll, Faezeh Shekari, Tang Long Shen, Ana Claudia Torrecilhas, Xiaomei Yan, Fuquan Yang, Hang Yin, Yu Xiao, Zezhou Zhao, Xue Zou, Qian Wang & Lei Zheng. (2020) The future of Extracellular Vesicles as Theranostics – an ISEV meeting report. Journal of Extracellular Vesicles 9:1.
Read now

Articles from other publishers (86)

Rui Zheng, Si Wang, Jia Wang, Mengnan Zhou, Qi Shi & Beixing Liu. (2023) Neuromedin U regulates the anti‐tumor activity of CD8 + T cells and glycolysis of tumor cells in the tumor microenvironment of pancreatic ductal adenocarcinoma in an NMUR1‐dependent manner . Cancer Science.
Crossref
Sofia Batalha, Catarina Monteiro Gomes & Catarina Brito. (2023) Immune microenvironment dynamics of HER2 overexpressing breast cancer under dual anti-HER2 blockade. Frontiers in Immunology 14.
Crossref
Yujin Lee, Jie Ni, Valerie C. Wasinger, Peter Graham & Yong Li. (2023) Comparison Study of Small Extracellular Vesicle Isolation Methods for Profiling Protein Biomarkers in Breast Cancer Liquid Biopsies. International Journal of Molecular Sciences 24:20, pages 15462.
Crossref
Sara Cherradi, Nicolas Taulet & Hong Tuan Duong. (2023) An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk. In vitro models.
Crossref
T.A. Bogush, A.A. Basharin, A.M. Scherbakov, K.I. Chandran, A.L. Mikhailova, I.P. Romanov, E.A. Bogush & V.S. Kosorukov. (2023) TUMOR CELL PANEL WITH CHARACTERIZED EXPRESSION OF PD-L1 FOR PRECLINICAL STUDIES OF ANTICANCER DRUGS AND IMMUNE CHECKPOINT INHIBITORS INTERACTION. Lomonosov chemistry journal 64:№1, 2023, pages 26-34.
Crossref
Ranvir Bhatia, Joanna Chang, Jessian L. Munoz & Nykia D. Walker. (2023) Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy. Biomedicines 11:6, pages 1614.
Crossref
Enea Ferlizza, Donatella Romaniello, Francesco Borrelli, Federica Pagano, Cinzia Girone, Valerio Gelfo, Rikke Sofie Kuhre, Alessandra Morselli, Martina Mazzeschi, Michela Sgarzi, Daria Maria Filippini, Gabriele D’Uva & Mattia Lauriola. (2023) Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression. Cancers 15:11, pages 2970.
Crossref
Sylvain Loric, Jérôme Alexandre Denis, Cédric Desbene, Michèle Sabbah & Marc Conti. (2023) Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management. International Journal of Molecular Sciences 24:8, pages 7208.
Crossref
Yujin Lee, Peter Graham & Yong Li. (2023) Extracellular vesicles as a novel approach for breast cancer therapeutics. Cancer Letters 555, pages 216036.
Crossref
N. Shen, M. Maggio, I. Woods, M. C. Lowry, R. Almasri, C. Gorgun, K.F. Eichholz, E. Stavenschi, K. Hokamp, F.M. Roche, L. O’Driscoll & D.A. Hoey. (2023) Mechanically activated mesenchymal-derived bone cells drive vessel formation via an extracellular vesicle mediated mechanism. Journal of Tissue Engineering 14.
Crossref
Lingyun Feng, Lijuan Guo, Yoshimasa Tanaka & Li Su. (2022) Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance. International Journal of Molecular Sciences 23:23, pages 15236.
Crossref
T. A. Bogush, A. A. Basharina, A. M. Scherbakov, K. I. Chandran, A. L. Mikhailova, I. P. Romanov, E. A. Bogush & V. S. Kosorukov. (2023) Tumor Cell Panel with Characterized Expression of PD-L1 for Preclinical Studies of Anticancer Drugs and Immune Checkpoint Inhibitors’ Interaction. Moscow University Chemistry Bulletin 77:S1, pages S19-S24.
Crossref
Hugo Veyssière, Yannick Bidet, Frederique Penault-Llorca, Nina Radosevic-Robin & Xavier Durando. (2022) Circulating proteins as predictive and prognostic biomarkers in breast cancer. Clinical Proteomics 19:1.
Crossref
Qiurong Yang, Jing Xu, Jianmei Gu, Hui Shi, Jiayin Zhang, Jianye Zhang, Zhe‐Sheng Chen, Xinjian Fang, Taofeng Zhu & Xu Zhang. (2022) Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. Advanced Science 9:34.
Crossref
Jeanesse Scerri, Christian Scerri, Felix Schäfer-Ruoff, Simon Fink, Markus Templin & Godfrey Grech. (2022) PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer. Frontiers in Endocrinology 13.
Crossref
Zhen-hao Wang, Zhuo-qun Zheng, Shi−cheng Jia, Shu-ni Liu, Xiao-fen Xiao, Guan-yuan Chen, Wei-quan Liang & Xiao-feng Lu. (2022) Trastuzumab resistance in HER2-positive breast cancer: Mechanisms, emerging biomarkers and targeting agents. Frontiers in Oncology 12.
Crossref
Kazumasa Oya, Larina Tzu-Wei Shen, Kazushi Maruo & Satoshi Matsusaka. (2022) Plasma Exchange May Enhance Antitumor Effects by Removal of Soluble Programmed Death-Ligand 1 and Extracellular Vesicles: Preliminary Study. Biomedicines 10:10, pages 2483.
Crossref
Reza Hosseini, Leila Asef-Kabiri, Hamzeh Sarvnaz, Alireza Ghanavatinejad, Fatemeh Rezayat, Nahid Eskandari & Mohammad Esmaeil Akbari. (2022) Blockade of exosome release alters HER2 trafficking to the plasma membrane and gives a boost to Trastuzumab. Clinical and Translational Oncology 25:1, pages 185-198.
Crossref
Hyein Jo, Kyeonghee Shim & Dooil Jeoung. (2022) Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance. International Journal of Molecular Sciences 23:17, pages 9592.
Crossref
Stefano Palazzolo, Vincenzo Canzonieri & Flavio Rizzolio. (2022) The history of small extracellular vesicles and their implication in cancer drug resistance. Frontiers in Oncology 12.
Crossref
Ai Nakaoka, Kana Kobayashi, Mennaallah Hassan & Ryohei Sasaki. 2022. Extracellular Vesicles - Role in Diseases, Pathogenesis and Therapy. Extracellular Vesicles - Role in Diseases, Pathogenesis and Therapy.
Noortje Verschoor, Teoman Deger, Agnes Jager, Stefan Sleijfer, Saskia M. Wilting & John W.M. Martens. (2022) Validity and utility of HER2/ERBB2 copy number variation assessed in liquid biopsies from breast cancer patients: A systematic review. Cancer Treatment Reviews 106, pages 102384.
Crossref
Mark Samuels, Chiara Cilibrasi, Panagiotis Papanastasopoulos & Georgios Giamas. (2022) Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment. Biomolecules 12:1, pages 132.
Crossref
Huey-Jen Lin, Yingguang Liu, Denene Lofland & Jiayuh Lin. (2022) Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity. Cancers 14:2, pages 285.
Crossref
Mao Shang, Yajing Chi, Jianbo Zhang, Jin Chang, Hui Yang, Sha Yin, Qiaorui Tan, Xiaochu Man & Huihui Li. (2022) The Therapeutic Effectiveness of Neoadjuvant Trastuzumab Plus Chemotherapy for HER2-Positive Breast Cancer Can Be Predicted by Tumor-Infiltrating Lymphocytes and PD-L1 Expression. Frontiers in Oncology 11.
Crossref
Paras Famta, Saurabh Shah, Dharmendra Kumar Khatri, Santosh Kumar Guru, Shashi Bala Singh & Saurabh Srivastava. (2022) Enigmatic role of exosomes in breast cancer progression and therapy. Life Sciences 289, pages 120210.
Crossref
Patrycja Przygodzka, Ewelina Sochacka, Kamila Soboska, Marcin Pacholczyk, Izabela Papiewska-Pająk, Tomasz Przygodzki, Przemysław Płociński, Steven Ballet, An De Prins & Joanna Boncela. (2021) Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Bo Shao, Qin Dang, Zhuang Chen, Chen Chen, Quanbo Zhou, Bingbing Qiao, Jinbo Liu, Shengyun Hu, Guixian Wang, Weitang Yuan & Zhenqiang Sun. (2021) Effects of Tumor-Derived Exosome Programmed Death Ligand 1 on Tumor Immunity and Clinical Applications. Frontiers in Cell and Developmental Biology 9.
Crossref
Maria Giovanna Scioli, Sonia Terriaca, Elena Fiorelli, Gabriele Storti, Giulia Fabbri, Valerio Cervelli & Augusto Orlandi. (2021) Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives. International Journal of Molecular Sciences 22:19, pages 10572.
Crossref
Valentin Vautrot, Hafidha Bentayeb, Sébastien Causse, Carmen Garrido & Jessica Gobbo. (2021) Tumor-Derived Exosomes: Hidden Players in PD-1/PD-L1 Resistance. Cancers 13:18, pages 4537.
Crossref
Yan Tang & Chunsheng Hu. (2021) NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma. Disease Markers 2021, pages 1-11.
Crossref
Sara Santamaria, Maria Cristina Gagliani, Grazia Bellese, Silvia Marconi, Anastasia Lechiara, Martina Dameri, Cinzia Aiello, Erica Tagliatti, Patrizio Castagnola & Katia Cortese. (2021) Imaging of Endocytic Trafficking and Extracellular Vesicles Released Under Neratinib Treatment in ERBB2 + Breast Cancer Cells . Journal of Histochemistry & Cytochemistry 69:7, pages 461-473.
Crossref
Semir Vranic, Farhan S. Cyprian, Zoran Gatalica & Juan Palazzo. (2021) PD-L1 status in breast cancer: Current view and perspectives. Seminars in Cancer Biology 72, pages 146-154.
Crossref
Guoxu Zheng, Zhangyan Guo, Weimiao Li, Wenjin Xi, Baile Zuo, Rui Zhang, Weihong Wen, An-Gang Yang & Lintao Jia. (2021) Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab. Signal Transduction and Targeted Therapy 6:1.
Crossref
Cristina Catoni, Veronica Di Paolo, Elisabetta Rossi, Luigi Quintieri & Rita Zamarchi. (2021) Cell-Secreted Vesicles: Novel Opportunities in Cancer Diagnosis, Monitoring and Treatment. Diagnostics 11:6, pages 1118.
Crossref
Reza Hosseini, Leila Asef-Kabiri, Hassan Yousefi, Hamzeh Sarvnaz, Majid Salehi, Mohammad Esmaeil Akbari & Nahid Eskandari. (2021) The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells. Molecular Cancer 20:1.
Crossref
Benhui Liang, Ximin Hu, Yinghe Ding & Mujun Liu. (2020) Tumor‐derived exosomes in the PD‐1/PD‐L1 axis: Significant regulators as well as promising clinical targets. Journal of Cellular Physiology 236:6, pages 4138-4151.
Crossref
Gianluca Rompianesi, Marcello Di Martino, Alex Gordon-Weeks, Roberto Montalti & Roberto Troisi. (2021) Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. World Journal of Gastrointestinal Oncology 13:5, pages 332-350.
Crossref
Laura Bongiovanni, Anneloes Andriessen, Marca H. M. Wauben, Esther N. M. Nolte-’t Hoen & Alain de Bruin. (2021) Extracellular Vesicles: Novel Opportunities to Understand and Detect Neoplastic Diseases. Veterinary Pathology 58:3, pages 453-471.
Crossref
Chunli Tan, Wenbo Sun, Zhi Xu, Shuyi Zhu, Weizi Hu, Xiumei Wang, Yanyan Zhang, Guangqin Zhang, Zibin Wang, Yong Xu & Jinhai Tang. (2021) Small extracellular vesicles deliver TGF‐β1 and promote adriamycin resistance in breast cancer cells. Molecular Oncology 15:5, pages 1528-1542.
Crossref
Katja Goričar, Vita Dolžan & Metka Lenassi. (2021) Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology. Frontiers in Pharmacology 12.
Crossref
Giusi La Camera, Luca Gelsomino, Amanda Caruso, Salvatore Panza, Ines Barone, Daniela Bonofiglio, Sebastiano Andò, Cinzia Giordano & Stefania Catalano. (2021) The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer. Cancers 13:5, pages 1160.
Crossref
Róisín Daly & Lorraine O’Driscoll. (2021) Extracellular vesicles in blood: are they viable as diagnostic and predictive tools in breast cancer?. Drug Discovery Today 26:3, pages 778-785.
Crossref
Lucrecia Agnetti, Chiara Fondello, María Florencia Arbe, Gerardo C. Glikin & Liliana M. E. Finocchiaro. (2020) Particulate mediators of the bystander effect linked to suicide and interferon-β transgene expression in melanoma cells. Gene Therapy 28:1-2, pages 38-55.
Crossref
Heidi Schwarzenbach & Peter B. Gahan. (2021) Exosomes in Immune Regulation. Non-Coding RNA 7:1, pages 4.
Crossref
Jesse D. Armitage, Hannah V. Newnes, Alison McDonnell, Anthony Bosco & Jason Waithman. (2021) Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression. Cells 10:1, pages 56.
Crossref
Marzia Del Re, Ron H.N. van Schaik, Stefano Fogli, Ron H.J. Mathijssen, Federico Cucchiara, Annalisa Capuano, Cristina Scavone, Guido W. Jenster & Romano Danesi. (2021) Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188463.
Crossref
Jie Zhang, Qianqian Song, Mengna Wu & Wenjie Zheng. (2020) The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma. Current Medicinal Chemistry 28:1, pages 93-109.
Crossref
Narges Dastmalchi, Reza Safaralizadeh, Amir Baghbanzadeh, Khalil Hajiasgharzadeh, Elmira Roshani Asl, Mohammad Amini & Behzad Baradaran. (2020) Molecular mechanisms of breast cancer chemoresistance by immune checkpoints. Life Sciences 263, pages 118604.
Crossref
Laura C. Zanetti-Domingues, Scott E. Bonner, Marisa L. Martin-Fernandez & Veronica Huber. (2020) Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles. Cells 9:11, pages 2505.
Crossref
Xingli Dong, Xupeng Bai, Jie Ni, Hao Zhang, Wei Duan, Peter Graham & Yong Li. (2020) Exosomes and breast cancer drug resistance. Cell Death & Disease 11:11.
Crossref
Jun Yang, Gokhan Bahcecioglu & Pinar Zorlutuna. (2020) The Extracellular Matrix and Vesicles Modulate the Breast Tumor Microenvironment. Bioengineering 7:4, pages 124.
Crossref
Ting Yang, Ziyi Fu, Yin Zhang, Min Wang, Changfei Mao & Weihong Ge. (2020) Serum proteomics analysis of candidate predictive biomarker panel for the diagnosis of trastuzumab-based therapy resistant breast cancer. Biomedicine & Pharmacotherapy 129, pages 110465.
Crossref
Hae Hyun Jung, Ji-Yeon Kim, Ji Eun Lim & Young-Hyuck Im. (2020) Cytokine profiling in serum-derived exosomes isolated by different methods. Scientific Reports 10:1.
Crossref
Zilong Wu, Zihao Xu, Boyao Yu, Jingtao Zhang & Bentong Yu. (2020) The Potential Diagnostic Value of Exosomal Long Noncoding RNAs in Solid Tumors: A Meta-Analysis and Systematic Review. BioMed Research International 2020, pages 1-15.
Crossref
Giuseppina Augimeri, Giusi La Camera, Luca Gelsomino, Cinzia Giordano, Salvatore Panza, Diego Sisci, Catia Morelli, Balázs Győrffy, Daniela Bonofiglio, Sebastiano Andò, Ines Barone & Stefania Catalano. (2020) Evidence for Enhanced Exosome Production in Aromatase Inhibitor-Resistant Breast Cancer Cells. International Journal of Molecular Sciences 21:16, pages 5841.
Crossref
Cinzia Giordano, Giusi La Camera, Luca Gelsomino, Ines Barone, Daniela Bonofiglio, Sebastiano Andò & Stefania Catalano. (2020) The Biology of Exosomes in Breast Cancer Progression: Dissemination, Immune Evasion and Metastatic Colonization. Cancers 12:8, pages 2179.
Crossref
M. Sorokin, K. Ignatev, V. Barbara, U. Vladimirova, A. Muraveva, M. Suntsova, N. Gaifullin, I. Vorotnikov, D. Kamashev, A. Bondarenko, M. Baranova, E. Poddubskaya & A. Buzdin. (2020) Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels. Biochemistry (Moscow) 85:7, pages 758-772.
Crossref
Yoojung Kwon, Misun Kim, Youngmi Kim, Hyun Suk Jung & Dooil Jeoung. (2020) Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages. Frontiers in Immunology 11.
Crossref
Yujie Shen, Shikun Dong, Jinhui Liu, Liqing Zhang, Jiacheng Zhang, Han Zhou & Weida Dong. (2020) Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets. BioMed Research International 2020, pages 1-21.
Crossref
Dhouha Daassi, Kathleen M. Mahoney & Gordon J. Freeman. (2020) The importance of exosomal PDL1 in tumour immune evasion. Nature Reviews Immunology 20:4, pages 209-215.
Crossref
Regina Padmanabhan, Hadeel Shafeeq Kheraldine, Nader Meskin, Semir Vranic & Ala-Eddin Al Moustafa. (2020) Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models. Cancers 12:3, pages 636.
Crossref
Adeleh Taghikhani, Farzin Farzaneh, Farzaneh Sharifzad, Soura Mardpour, Marzieh Ebrahimi & Zuhair Mohammad Hassan. (2020) Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy. Frontiers in Immunology 11.
Crossref
Hui-Yi Xue, Reina Bendayan & Ho-Lun Wong. 2020. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy 121 147 .
Jia-Hong Chen, Alexander T. H. Wu, Oluwaseun Adebayo Bamodu, Vijesh Kumar Yadav, Tsu-Yi Chao, Yew-Min Tzeng, Debabrata Mukhopadhyay, Michael Hsiao & Jih-Chin Lee. (2019) Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts. Cancers 12:1, pages 56.
Crossref
Aadya Nagpal, Richard P. Redvers, Xiawei Ling, Scott Ayton, Miriam Fuentes, Elnaz Tavancheh, Irmina Diala, Alshad Lalani, Sherene Loi, Steven David, Robin L. Anderson, Yvonne Smith, Delphine Merino, Delphine Denoyer & Normand Pouliot. (2019) Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis. Breast Cancer Research 21:1.
Crossref
HuiSu Kim, Dong Wook Kim & Je-Yoel Cho. (2019) Exploring the key communicator role of exosomes in cancer microenvironment through proteomics. Proteome Science 17:1.
Crossref
Ladan Mashouri, Hassan Yousefi, Amir Reza Aref, Ali mohammad Ahadi, Fatemeh Molaei & Suresh K. Alahari. (2019) Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Molecular Cancer 18:1.
Crossref
Xiaojie Bian, Yu-Tian Xiao, Tianqi Wu, Mengfei Yao, Leilei Du, Shancheng Ren & Jianhua Wang. (2019) Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression. Molecular Cancer 18:1.
Crossref
Selma Maacha, Ajaz A. Bhat, Lizandra Jimenez, Afsheen Raza, Mohammad Haris, Shahab Uddin & Jean-Charles Grivel. (2019) Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Molecular Cancer 18:1.
Crossref
M. Helena Vasconcelos, Hugo R. Caires, Artūrs Ābols, Cristina P.R. Xavier & Aija Linē. (2019) Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance. Drug Resistance Updates 47, pages 100647.
Crossref
Munmun Panda & Bijesh K. Biswal. (2019) Cell signaling and cancer: a mechanistic insight into drug resistance. Molecular Biology Reports 46:5, pages 5645-5659.
Crossref
Hong-Xia Wang & Olivier Gires. (2019) Tumor-derived extracellular vesicles in breast cancer: From bench to bedside. Cancer Letters 460, pages 54-64.
Crossref
Claudio Vernieri, Monica Milano, Marta Brambilla, Alessia Mennitto, Claudia Maggi, Maria Silvia Cona, Michele Prisciandaro, Chiara Fabbroni, Luigi Celio, Gabriella Mariani, Giulia Valeria Bianchi, Giuseppe Capri & Filippo de Braud. (2019) Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives. Critical Reviews in Oncology/Hematology 139, pages 53-66.
Crossref
Denis M. Collins, Neil T. Conlon, Srinivasaraghavan Kannan, Chandra S. Verma, Lisa D. Eli, Alshad S. Lalani & John Crown. (2019) Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer. Cancers 11:6, pages 737.
Crossref
Lin Zhang & Dihua Yu. (2019) Exosomes in cancer development, metastasis, and immunity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1871:2, pages 455-468.
Crossref
Aamir Ahmad. 2019. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance 217 228 .
Minjeong Yeon, Jaewhan Byun, Hyuna Kim, Misun Kim, Hyun Suk Jung, Doyong Jeon, Youngmi Kim & Dooil Jeoung. (2018) CAGE Binds to Beclin1, Regulates Autophagic Flux and CAGE-Derived Peptide Confers Sensitivity to Anti-cancer Drugs in Non-small Cell Lung Cancer Cells. Frontiers in Oncology 8.
Crossref
Ruihao Zhou, Kaddie Kwok Chen, Jingtao Zhang, Bufan Xiao, Zhaohao Huang, Cheng Ju, Jun Sun, Feifei Zhang, Xiao-Bin Lv & Guofu Huang. (2018) The decade of exosomal long RNA species: an emerging cancer antagonist. Molecular Cancer 17:1.
Crossref
Niamh Mc Namee & Lorraine O'Driscoll. (2018) Extracellular vesicles and anti-cancer drug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1870:2, pages 123-136.
Crossref
Andrea Nicolini, Paola Ferrari, Giuseppe Rossi & Angelo Carpi. (2018) Tumour growth and immune evasion as targets for a new strategy in advanced cancer. Endocrine-Related Cancer 25:11, pages R577-R604.
Crossref
Chunli Tan, Weizi Hu, Yunjie He, Yanyan Zhang, Guangqin Zhang, Yong Xu & Jinhai Tang. (2018) Cytokine-mediated therapeutic resistance in breast cancer. Cytokine 108, pages 151-159.
Crossref
Michelle C. Lowry & Lorraine O’Driscoll. (2018) Can hi-jacking hypoxia inhibit extracellular vesicles in cancer?. Drug Discovery Today 23:6, pages 1267-1273.
Crossref
Mark D. PegramYu ZongClinton YamMatthew P. GoetzStacy L. Moulder. (2018) Innovative Strategies: Targeting Subtypes in Metastatic Breast Cancer. American Society of Clinical Oncology Educational Book:38, pages 65-77.
Crossref
Esther Schwich & Vera Rebmann. (2018) The Inner and Outer Qualities of Extracellular Vesicles for Translational Purposes in Breast Cancer. Frontiers in Immunology 9.
Crossref
Tomofumi Yamamoto, Nobuyoshi Kosaka, Yutaka Hattori & Takahiro Ochiya. (2018) A Challenge to Aging Society by microRNA in Extracellular Vesicles: microRNA in Extracellular Vesicles as Promising Biomarkers and Novel Therapeutic Targets in Multiple Myeloma. Journal of Clinical Medicine 7:3, pages 55.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.